Syn-Med-Chemist-"Quintessential Synthetic Chemistry"---A Synthetic Chemist's Perception......
Sunday, September 27, 2015
Nivolumab drug significantly prolongs survival in advanced kidney cancer patients
Nivolumab drug significantly prolongs survival in advanced kidney cancer patients
Saturday, September 26, 2015
Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)
Amgen gets positive CHMP opinions for Kyprolis (carfilzomib) and BLINCYTO (blinatumomab)
Newer Posts
Older Posts
Home
Subscribe to:
Posts (Atom)
